Morgan Stanley Maintains Equal-Weight on Ovintiv, Lowers Price Target to $65
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE: OVV ) with a Equal-Weight and lowers the price target from $68 to $65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.